Peter Rawson Byron - Comment

Document ID: FDA-2013-N-0402-0002
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: May 30 2013, at 12:00 AM Eastern Daylight Time
Date Posted: June 4 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: May 9 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: June 7 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-85mg-tn4c
View Document:

This is comment on Proposed Rule

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives Public Hearing; Request for Comments

View Comment

Ensuring In Vitro and CFD Support for the Bioequivalence of Orally Inhaled Drug Products (Dr Peter Byron will present slides / slides to be submitted shortly)

Related Comments

Total: 4

Peter Rawson Byron - Comment
Public Submission Posted: 06/04/2013 ID: FDA-2013-N-0402-0002

Comment Period Closed
Jun 07,2013 11:59 PM ET

The People's Pharmacy - Comment
Public Submission Posted: 06/20/2013 ID: FDA-2013-N-0402-0003

Comment Period Closed
Jun 07,2013 11:59 PM ET

Waters Technologies Corporation - Comment
Public Submission Posted: 06/20/2013 ID: FDA-2013-N-0402-0004

Comment Period Closed
Jun 07,2013 11:59 PM ET

Richard H Guy - Comment
Public Submission Posted: 06/20/2013 ID: FDA-2013-N-0402-0005

Comment Period Closed
Jun 07,2013 11:59 PM ET